Overview

A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding

Status:
Completed

Trial end date:
2021-07-12

Target enrollment:

Participant gender:

Summary

To evaluate the safety and efficacy of vilaprisan in Japanese subjects with uterine fibroids and heavy menstrual bleeding (HMB).

Phase:

Phase 3

Details

Lead Sponsor:

Bayer